Live Breaking News & Updates on Endocrine society guidelines

Stay informed with the latest breaking news from Endocrine society guidelines on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Endocrine society guidelines and stay connected to the pulse of your community

Ascendis Pharma (ASND) Announces UK Approval of YORVIPATH

Ascendis Pharma (ASND) Announces UK Approval of YORVIPATH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , Japan , United-states , United-kingdom , Great-britain , Canadian , Ascendis-pharma , European-society-of-endocrinology-consensus-statement , European-commission , European-medicines-agency , Endocrine-society-guidelines , Regulatory-agency

United Kingdom's MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism

COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH® (palopegteriparatide; developed as TransCon™ PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism, and has also granted YORVIPATH orphan drug status. YORVIPATH is a prod

Copenhagen , Køavn- , Denmark , United-states , United-kingdom , Japan , Canada , Canadian , Great-britain , Ascendis-pharma , Endocrine-society-guidelines , European-commission

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss

Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Tufts-university , Massachusetts , Albany-medical-college , Miami , Florida , California , Berkeley , Cornell-university , Boston , America

Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for Adults with Chronic Hypoparathyroidism -January 31, 2024 at 04:02 pm EST

COPENHAGEN, Denmark, Jan. 31, 2024 -- Ascendis Pharma A/S today announced that YORVIPATH® , a parathyroid hormone replacement therapy indicated for the treatment of adults with chronic...

United-kingdom , Austria , Denmark , Canada , China , Copenhagen , Køavn- , Germany , Japan , Russia , Ukraine , United-states

Vitamin D decreases effects of high fructose corn syrup

High fructose corn syrup may have detrimental effects on brain health and function, but data from a new animal study suggests vitamin D may decrease the number of HFCS-related degenerative neurons, and positively affect learning and memory performance.

Turkey , Suleyman-demirel-university , Morris , Endocrine-society-guidelines , Behavioural-brain-research , Behavioural-brain , Getty-images-iryna-imago , Iryna-imago , Research , Upplements , Itamins-amp-premixes

Vitamin D decreases effects of high fructose corn syrup

High fructose corn syrup may have detrimental effects on brain health and function, but data from a new animal study suggests vitamin D may decrease the number of HFCS-related degenerative neurons, and positively affect learning and memory performance.

Turkey , Morris , Endocrine-society-guidelines , Behavioural-brain-research , Suleyman-demirel-university , Behavioural-brain , Getty-images-iryna-imago , Iryna-imago , Research , Ognitive-function , Ealthy-aging

Prenatal vitamin D may reduce child's asthma risk: Harvard study

High-dose vitamin D during pregnancy may significantly reduce asthma in the offspring at both age three and six, compared to a standard prenatal multivitamin with vitamin D, says a new study.

Boston-university , Massachusetts , United-states , Boston , Americans , Blood-institute , Us-national-heart , Harvard-medical-school , Endocrine-society-guidelines , Vitamind-antenatal-asthma-reduction-trial , Clinical-immunology

Prenatal vitamin D may reduce child's asthma risk: Harvard study

High-dose vitamin D during pregnancy may significantly reduce asthma in the offspring at both age three and six, compared to a standard prenatal multivitamin with vitamin D, says a new study.

Boston , Massachusetts , United-states , Boston-university , Americans , Endocrine-society-guidelines , Us-national-heart , Harvard-medical-school , Blood-institute , Vitamind-antenatal-asthma-reduction-trial , Clinical-immunology

Amici urging 7th Circuit to overturn injunction against law banning gender-transition procedures for minors

Multiple amici have filed briefs urging the 7th Circuit Court of Appeals to overturn an injunction against a new Indiana law that prohibits doctors from performing gender-transition procedures on minors.

Nebraska , United-states , Kentucky , South-carolina , Alabama , Tennessee , Texas , Iowa , Indiana , Oklahoma , West-virginia , Alaska

Opinion: The truth about gender-affirming care laws emerges

Over the past two years, 19 deep red states have passed laws that either ban medical care to transgender minors outright or criminalize doctors providing such care. All but three

Kentucky , United-states , Tennessee , Arkansas , Idaho , American , American-psychiatric-association , American-medical-association , A-supreme-court , American-academy-of-pediatrics , American-academy-of-child-development